Maureen Dubreuil, MD, MSc.
Associate Professor, Medicine
Biography
Dr. Dubreuil is a rheumatologist in Boston, specializing in spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. Dr. Dubreuil’s research has been funded by numerous competitive grants from funders including the NIH, private foundations and industry. Some highlights of Dr. Dubreuil’s work includes:
1. Discovery of two key protective effects of TNF inhibitors against fractures and cardiovascular events in spondyloarthritis
2. Finding that a common nonsteroidal anti-inflammatory drug is associated with 3 times the risk of heart attack among people with spondyloarthritis
3. Development of the first North American guidelines for referral of adults at increased risk of having spondyloarthritis to a rheumatologist
In addition to her research, Dr. Dubreuil is a member of the leading international organizations for spondyloarthritis research. She serves on the Executive Committee of the Board of Directors for the Spondyloarthritis Research and Treatment Network, and on the Medical Advisory Board for the Spondylitis Association of America. She is a site investigator for the international CLASSIC study in spondyloarthritis. Dr. Dubreuil is the Director of Research Training for the Rheumatology Fellowship program at Boston Medical Center.
Dr. Dubreuil cares for people with rheumatic conditions at Boston Medical Center and the VA Boston Healthcare System. Dr. Dubreuil’s patients say the following about her:
“Dr. Dubreuil is a very caring and knowledgeable doctor and it’s always a pleasure to be seen by her.”
“We talked about my medical history [she] gave me suggestions and gave me referrals so I would say it was very pleasant and formal and wonderful”
“Dr. Dubreuil is a gem and I feel so lucky to have her!”
Other Positions
- Member, Arthritis & Autoimmune Diseases Research Center, Boston University
- VA Boston Healthcare System
Websites
- BU Profile
- Dr. Dubreuil's publications on PubMed
- Dr. Dubreuil's profile on LinkedIn
- Rheumatology Faculty at BU Medical Center
- BU Rheumatology
- BU Musculoskeletal Clinical Research Collaboratory
- American College of Rheumatology Abstracts by Dr. Dubreuil
- ACR On Air Podcast Episode: Treating Spondyloarthritis
- BU Rheumatology Fellowship Program Video
- An interview on WebMD about Ankylosing Spondylitis
- SPARTAN (Spondyloarthritis Research and Treatment Network)
- Spondylitis Association of America
- Dr. Dubreuil's ABIM Certification in Rheumatology
Education
- University of Connecticut School of Medicine, MD
- Boston University School of Public Health, MSc
- Rochester Institute of Technology, BS
Publications
- Published on 6/4/2024
Dubreuil M, Navarro-Compán V, Boonen A, Gaffney K, Gensler LS, de la Loge C, Vaux T, Fleurinck C, Massow U, Taieb V, Mørup MF, Deodhar A, Rudwaleit M. Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies. RMD Open. 2024 Jun 04; 10(2). PMID: 38834351.
Read at: PubMed - Published on 6/2/2024
Liew JW, Treu T, Park Y, Ferguson JM, Rosser MA, Ho YL, Gagnon DR, Stovall R, Monach P, Heckbert SR, Gensler LS, Liao KP, Dubreuil M. The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2024 Oct; 68:152482. PMID: 38865875.
Read at: PubMed - Published on 2/10/2024
Dubreuil M. Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings. Curr Rheumatol Rep. 2024 May; 26(5):164-169. PMID: 38340269.
Read at: PubMed - Published on 2/6/2024
Jinno S, Onishi A, Hattori S, Dubreuil M, Ueda Y, Nishimura K, Okano T, Yamada H, Yamamoto W, Murata K, Onizawa H, Ebina K, Maeda Y, Son Y, Amuro H, Hara R, Hata K, Shiba H, Katayama M, Watanabe R, Hashimoto M, Saegusa J. Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study. Rheumatology (Oxford). 2024 Feb 06. PMID: 38317442.
Read at: PubMed - Published on 9/21/2023
Bittar M, Nouer SS, Tolley EA, Dubreuil M, Magrey M. Mortality and Ankylosing Spondylitis in the US population: leading causes and associated factors. Clin Rheumatol. 2024 Jan; 43(1):227-232. PMID: 37733078.
Read at: PubMed - Published on 9/7/2023
George N, Liew JW, Dubreuil M. The role of upadacitinib for the treatment of axial spondyloarthritis. Immunotherapy. 2023 Oct; 15(15):1227-1237. PMID: 37675498.
Read at: PubMed - Published on 8/22/2023
Merjanah S, Liew JW, Bihn J, Fillmore NR, Brophy MT, Do NV, Dubreuil M. Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2023 Dec; 75(12):2481-2488. PMID: 37308459.
Read at: PubMed - Published on 4/10/2023
Beaudette-Zlatanova B, Lew RA, Otis JD, Branch-Elliman W, Bacorro E, Dubreuil M, Eyvazzadeh C, Kaur M, Lazzari AA, Libbey C, Monach PA. Pilot Study of Low-dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-controlled, Crossover Clinical Trial. Clin Ther. 2023 May; 45(5):468-477. PMID: 37045708.
Read at: PubMed - Published on 2/23/2023
Kumar D, Neogi T, Peloquin C, Marinko L, Camarinos J, Aoyagi K, Felson DT, Dubreuil M. Delayed timing of physical therapy initiation increases the risk of future opioid use in individuals with knee osteoarthritis: a real-world cohort study. Br J Sports Med. 2023 Aug; 57(15):958-964. PMID: 36822841.
Read at: PubMed - Published on 2/14/2023
Machado PM, Schäfer M, Mahil SK, Liew J, Gossec L, Dand N, Pfeil A, Strangfeld A, Regierer AC, Fautrel B, Alonso CG, Saad CGS, Griffiths CEM, Lomater C, Miceli-Richard C, Wendling D, Alpizar Rodriguez D, Wiek D, Mateus EF, Sirotich E, Soriano ER, Ribeiro FM, Omura F, Rajão Martins F, Santos H, Dau J, Barker JN, Hausmann J, Hyrich KL, Gensler L, Silva L, Jacobsohn L, Carmona L, Pinheiro MM, Zelaya MD, Severina MLÁ, Yates M, Dubreuil M, Gore-Massy M, Romeo N, Haroon N, Sufka P, Grainger R, Hasseli R, Lawson-Tovey S, Bhana S, Pham T, Olofsson T, Bautista-Molano W, Wallace ZS, Yiu ZZN, Yazdany J, Robinson PC, Smith CH. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Ann Rheum Dis. 2023 May; 82(5):698-709. PMID: 36787993.
Read at: PubMed
View 53 more publications: View full profile at BUMC